CPH 0.00% 0.9¢ creso pharma limited

Ann: Creso Pharma Announces Three New Board Appointments, page-31

  1. 705 Posts.
    lightbulb Created with Sketch. 134
    SPOT ON.. William Lay specialises in M&A... and its not difficult to just buy over a company with recurring sales.. and you shareholderes wont gget to say no.. cause consolidation of power is at the board level. Your votes dont count.. well at least its not enough.


 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.